Corporate Social Responsibility (CSR) as part of the business strategy of pharmaceutical companies

Kliknij autora aby wyszukać wszystkie publikowane przez niego artykuły:
Beata Jankowiak-Bolko, Włodzimierz Samborski, Ewa Mojs

3 (48) 2016 s. 314–326
Click to return to issue contents
314_3_48_2016.pdf
Digital version of article (in PDF file)

DOI: https://doi.org/10.20883/ppnoz.2016.17

Fraza do cytowania: Jankowiak-Bolko B., Samborski W., Mojs E. Corporate Social Responsibility (CSR) as part of the business strategy of pharmaceutical companies. Polski Przegląd Nauk o Zdrowiu. 2016;3(48):314–326. DOI: https://doi.org/10.20883/ppnoz.2016.17

The development of the pharmaceutical market also in Poland has brought about changes in strategies of organizations. Companies are not just interested in increasing profits and brand recognition but they also care for building the company image as a business working for the benefit of the social health. The main objective of activities undertaken as part of corporate social responsibility (CSR) strategy of pharmaceutical companies is pro-health education, promotion of activities aimed at prevention and health protection, as well as the overall improvement of the health of the society. The aim of the article is to present CSR activities undertaken by pharmaceutical companies operating on the Polish market.

Key words: pharmaceuticals market, corporate social responsibility, social engagement of pharmaceutical companies.



Copyright © 1989–2022 Polish Review of Health Sciences. All rights reserved.